These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21422924)

  • 1. Dysregulated mineral metabolism in children with chronic kidney disease.
    Shroff R
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):233-40. PubMed ID: 21422924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation?
    Shroff R; Quinlan C; Mitsnefes M
    Pediatr Nephrol; 2011 Jun; 26(6):853-65. PubMed ID: 21080003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular calcification in chronic kidney disease: pathogenesis and clinical implications.
    Shioi A; Nishizawa Y
    J Ren Nutr; 2009 Jan; 19(1):78-81. PubMed ID: 19121777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease.
    Caudrillier A; Mentaverri R; Brazier M; Kamel S; Massy ZA
    J Nephrol; 2010; 23(1):17-22. PubMed ID: 20091482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular calcification in patients with chronic kidney disease.
    Nitta K
    Ther Apher Dial; 2011 Dec; 15(6):513-21. PubMed ID: 22107687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease.
    Nikolov IG; Mozar A; Drüeke TB; Massy ZA
    Blood Purif; 2009; 27(4):350-9. PubMed ID: 19295198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineral metabolism disturbances in patients with chronic kidney disease.
    Kestenbaum B; Belozeroff V
    Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
    Martin KJ; González EA
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF23: a key player in mineral and bone disorder in CKD.
    Komaba H; Fukagawa M
    Nefrologia; 2009; 29(5):392-6. PubMed ID: 19820750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular calcification in uremic conditions: new insights into pathogenesis.
    Cozzolino M; Gallieni M; Brancaccio D
    Semin Nephrol; 2006 Jan; 26(1):33-7. PubMed ID: 16412823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphate toxicity and vascular mineralization.
    Razzaque MS
    Contrib Nephrol; 2013; 180():74-85. PubMed ID: 23652551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Atheroma and vascular calcification in hemodialysis patients].
    Joki N; Tanaka Y
    Clin Calcium; 2010 Jul; 20(7):1061-6. PubMed ID: 20585185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
    Inaguma D; Tatematsu M
    Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.
    Saab G; Whaley-Connell AT; Khanna R; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular calcification and disordered mineral metabolism in dialysis patients.
    Kalpakian MA; Mehrotra R
    Semin Dial; 2007; 20(2):139-43. PubMed ID: 17374088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Roles of hyperphosphatemia in vascular calcification].
    Shioi A; Nishizawa Y
    Clin Calcium; 2009 Feb; 19(2):180-5. PubMed ID: 19182356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.
    Cunningham J; Locatelli F; Rodriguez M
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):913-21. PubMed ID: 21454719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vascular calcification in chronic kidney disease].
    Cozzolino M; Missaglia E; Ortiz A; Bellasi A; Adragao T; Apostolous T; Vescovo G; Gallieni M
    Recenti Prog Med; 2010 Nov; 101(11):442-52. PubMed ID: 21197764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CKD-MBD: an endless story.
    Brancaccio D; Cozzolino M
    J Nephrol; 2011; 24 Suppl 18():S42-8. PubMed ID: 21623582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.